ROSLINCT
RoslinCT is a UK Cell Therapy Contract Development and Manufacturing Organisation focused on providing services for companies developing cell-based therapeutic products.
ROSLINCT
Social Links:
Industry:
Clinical Trials Manufacturing
Founded:
2006-01-01
Address:
Edinburgh, Edinburgh, City Of, United Kingdom
Country:
United Kingdom
Website Url:
http://www.roslinct.com
Total Employee:
11+
Status:
Active
Contact:
+44 (0) 131 658 5180
Email Addresses:
[email protected]
Total Funding:
1.16 M USD
Similar Organizations
ConvaTec
ConvaTec specializes in the development, manufacture, distribution of single-use devices to hospitals and healthcare sectors.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
RootPath Genomics
RootPath Genomics is a biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine.
Current Employees Featured
Investors List
GHO Capital
GHO Capital investment in Private Equity Round - RoslinCT
Innovate UK
Innovate UK investment in Grant - RoslinCT
Official Site Inspections
http://www.roslinct.com Semrush global rank: 8.17 M Semrush visits lastest month: 359
- Host name: static.156.187.161.5.clients.your-server.de
- IP address: 5.161.187.156
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "RoslinCT"
About RoslinCT | Cell Therapy CDMO
RoslinCT, as one of the first in the world to produce clinical-grade human pluripotent stem cells, has a strong focus on science and innovation. In collaboration with Vertex Pharmaceuticals, …See details»
RoslinCT - LinkedIn
RoslinCT is a leading global contract development and manufacturing services organization (CDMO) focused on Advanced Cell and Gene Therapies. Established in 2006 and built upon the groundbreaking ...See details»
RoslinCT - Crunchbase Company Profile & Funding
Organization. RoslinCT . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. RoslinCT is a UK Cell Therapy Contract …See details»
Member profile: RoslinCT | BIA
Oct 29, 2024 RoslinCT is a leading Cell Therapy Contract Development and Manufacturing Organisation (CDMO) enabling you to bring your autologous or allogeneic therapy safely to …See details»
RoslinCT Company Profile - Office Locations, Competitors ... - Craft
RoslinCT (Roslin Cell Therapies) is a contract manufacturing organization focused on providing process development services and GMP manufacturing solutions for companies developing …See details»
RoslinCT and Lykan Bioscience Combine to Create Leading
Aug 4, 2022 About RoslinCT. RoslinCT is a leading UK Cell Therapy Contract Development and Manufacturing Organisation (CDMO) focused on providing services for companies developing …See details»
RoslinCT and Lykan Bioscience Announce Integration …
Jun 5, 2023 RoslinCT is a leading global contract development and manufacturing services organization (CDMO) focused on Advanced Cell and Gene Therapies. Established in 2006 and built upon the groundbreaking …See details»
RoslinCT - Leadership Team - The Org
The Leadership Team at RoslinCT is responsible for setting the strategic direction and operational oversight of the organization, ensuring alignment across all departments to advance cell …See details»
RoslinCT and Lykan Bioscience Announce Integration …
Jun 5, 2023 EDINBURGH, U.K. and BOSTON, U.S., June 5, 2023 /PRNewswire/ -- RoslinCT and Lykan Bioscience, two leading Contract Development and Manufacturing Organizations (CDMOs) in the Cell and …See details»
RoslinCT US Holdings, LLC - MassBio
Mar 11, 2025 RoslinCT is a leading global contract development and manufacturing services organization (CDMO) focused on Advanced Cell and Gene Therapies. Established in 2006 …See details»
Roslin Cells - VentureRadar
" Roslin Cell Therapies Ltd, now trading as RoslinCT, is a leading UK Cell Therapy Contract Development and Manufacturing Organisation (CDMO) focused on providing services for …See details»
Cell Therapy Careers | RoslinCT
RoslinCT to manufacture FDA-Approved Cell Therapy Omisirge® for Gamida Cell Read the PR. About. RoslinCT History. Vision and Mission. Sustainability ... Proposals, and Program …See details»
RoslinCT - LinkedIn
RoslinCT is a leading global contract development and manufacturing services organization (CDMO) focused on Advanced Cell and Gene Therapies. Established in 2006 and built upon …See details»
Your trusted cell therapy CDMO partner | RoslinCT
With a strong history of FDA, MHRA, and EMA clearances and successful third-party audits, RoslinCT ensures global clinical and commercial manufacturing with adaptable cGMP …See details»
RoslinCT announces the construction of a new Cell & Gene …
Jun 26, 2020 RoslinCT - a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) - announces initiation of construction for the expansion of their new …See details»
RoslinCT and Ayrmid Pharma Ltd. Announce Their Intent to Enter …
Mar 11, 2025 RoslinCT is a leading global contract development and manufacturing services organization (CDMO) focused on Advanced Cell and Gene Therapies. Established in 2006 …See details»
RoslinCT and Ayrmid Pharma Ltd. Announce Their Intent to
Mar 11, 2025 RoslinCT is a leading global contract development and manufacturing services organization (CDMO) focused on Advanced Cell and Gene Therapies. Established in 2006 …See details»
RoslinCT and Lykan Bioscience Combine to Create Leading …
Aug 4, 2022 For further information, please visit www.roslinct.com. About Lykan Bioscience. Lykan Bioscience is an innovative contract development and manufacturing services …See details»
Advanced Cell & Gene Therapy CDMO Solutions | RoslinCT
RoslinCT, as one of the first in the world to produce clinical-grade human pluripotent stem cells, has a strong focus on science and innovation. In collaboration with Vertex Pharmaceuticals, …See details»
Sustainability - RoslinCT
The RoslinCT purpose-built facilities in the UK and the US, our focus on innovation, and collective experience enable our partners to deliver cost-effective and compliant cell-based therapies to …See details»